Alkhatib NS, Almutairi AR, Almadi M, Halloush S, et al. Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective. PLoS One 2024;19:e0312603.
PMID: 39531466